Trademark Overview
On Monday, December 8, 2025, a trademark application was filed for REMICINE with the United States Patent and Trademark Office. The USPTO has given the REMICINE trademark a serial number of 79441436. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Friday, April 10, 2026. This trademark is owned by Remicine Holding B.V.. The REMICINE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Research and development in the field of pharmaceuticals, biotechnology and medical technology; research and development of new products and treatments in the pharmaceutical and medical fields; consultancy in the field of pharmaceutical, biotechnological and medical innovation; technological development and scientific research in the pharmaceutical and medical fields.